William Blair & Company’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-50,485
Closed -$1.02M 1754
2018
Q4
$1.02M Sell
50,485
-17,485
-26% -$295K 0.01% 690
2018
Q3
$1.32M Sell
67,970
-44,259
-39% -$942K 0.01% 652
2018
Q2
$2.87M Buy
112,229
+58,859
+110% +$1.37M 0.02% 482
2018
Q1
$1.07M Buy
53,370
+13,025
+32% +$304K 0.01% 699
2017
Q4
$810K Buy
+40,345
New +$793K 0.01% 804
2017
Q2
Sell
-17,489
Closed -$238K 1692
2017
Q1
$238K Buy
17,489
+670
+4% +$9.66K ﹤0.01% 1162
2016
Q4
$212K Sell
16,819
-73,650
-81% -$1.37M ﹤0.01% 1140
2016
Q3
$2.53M Sell
90,469
-18,060
-17% -$606K 0.02% 444
2016
Q2
$3.8M Sell
108,529
-7,255
-6% -$228K 0.04% 338
2016
Q1
$3.17M Buy
115,784
+20,885
+22% +$615K 0.03% 356
2015
Q4
$3.25M Sell
94,899
-263,386
-74% -$8.22M 0.03% 366
2015
Q3
$10.3M Buy
358,285
+349,150
+3,822% +$14.9M 0.09% 222
2015
Q2
$408K Buy
9,135
+2,400
+36% +$90.3K ﹤0.01% 1833
2015
Q1
$232K Buy
+6,735
New +$183K ﹤0.01% 1971

Other funds holding DPLO

William Blair & Company's DPLO Position: Q1 2019 in Review

William Blair & Company sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2019, closing a stake of 50,485 shares — an estimated $1.02M sold.

William Blair & Company first reported a position in DPLO in Q1 2015 and held it in 14 quarters. The position peaked at $10.3M in Q3 2015. 150 funds tracked by Wall St. Rank hold DPLO as of Q1 2019.

  • William Blair & Company reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2019 after selling out during the quarter.
  • William Blair & Company sold 50,485 DIPLOMAT PHARMACY, INC. shares in Q1 2019, an estimated $1.02M.
  • William Blair & Company first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2015 and held it in 14 quarters.
  • William Blair & Company's DIPLOMAT PHARMACY, INC. position peaked at $10.3M in Q3 2015.
  • 150 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2019.

Based on William Blair & Company's 13F filing for Q1 2019, filed 14 May 2019.